Healthcare leaders are increasingly aware of the power of technology and augmented intelligence (AI) to impact health equity. However, due to inconsistent collection of personal characteristic data (i.e. race, ethnicity, and language), multiple source systems that categorize and store characteristics differently, and no specific analytics for health equity, this task is overwhelming and often seems unattainable.
By building a systematic approach to evaluating health equity as a core part of its commitment to quality, your organization can apply AI to perform an equity analysis that evaluates a range of measures over multiple dimensions to identify success and opportunities for improvement.
Trudy Sullivan and Dr. Melissa Welch will discuss how to establish mechanisms using data you already have for ongoing health equity evaluation and how to drive data-informed decisions.
Sullivan leads Communications and Diversity & Inclusion efforts as a Health Catalyst leadership team member. She holds a Masters in Business Administration from Kellogg School of Management at Northwestern University, and a BA in History from the University of Portland, Oregon. Sullivan brings experience in B2B, B2C + B2G environments, from innovative high tech companies, including biomedical, semiconductor and aerospace & defense. She spent more than a decade in healthcare, including serving more than one hundred Pacific Northwest hospital customers, as CEO of an American Red Cross blood services region. Sullivan’s functional experience includes Operations Management; Human Resources; Marketing; Business Development; Strategy; M & A; Investor, Government + Community Relations; and Brand Development.
Melissa Welch, MD
Melissa Welch joined Health Catalyst in June 2022 as the Chief Medical Officer. An accomplished, senior physician executive with 35 years of leadership, management, and health care strategic impacts, Melissa’s career spans private and public healthcare sectors. She has successfully built physician and allied clinical teams, stabilized quality, and operations, and executed critical value-based care results. Prior to joining Health Catalyst, Melissa served in many roles, including Vice President of Clinical Quality, Network and Markets Support at Blue Shield of California, Head of Regional Care Management at Aetna, and Chief Medical Officer of San Francisco’s Community Health Network. Melissa began her career as a Medical Director of a community public health clinic. She holds a B.S. in Biology from the University of California Irvine, an MPH in Epidemiology from U.C. Berkeley, is a graduate of Harvard Medical School, and is Board Certified in Primary Care, Internal Medicine. Dr. Welch completed her residency training at U.C. San Francisco/ San Francisco General and was previously an Associate Clinical Professor of Medicine.